transformation related protein 53, pseudogene ; Mus musculus






3044 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
51 7557434 A splice donor site mutation results in the insertion of five extra amino acids into P53 from SEWA mouse sarcoma cells. Gene 1995 Sep 11 1
52 7559462 Modulation of interleukin-6-induced plasma protein secretion in hepatoma cells by p53 species. J Biol Chem 1995 Sep 29 1
53 7576102 Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein. Mol Carcinog 1995 Oct 6
54 7586136 Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Carcinogenesis 1995 Oct 2
55 7586156 K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 1995 Oct 5
56 7586183 Mutational and LOH analyses of p53 alleles in colon tumors induced by 1,2-dimethylhydrazine in F1 hybrid mice. Carcinogenesis 1995 Nov 1
57 7591269 Dominant-negative p53 can restore tumorigenicity of L-929 cells in immunocompetent mice. Int J Cancer 1995 Nov 15 1
58 7600534 Rare occurrence of p53 and ras gene mutations in preneoplastic and neoplastic mouse endometrial lesions induced by N-methyl-N-nitrosourea and 17 beta-estradiol. Cancer Lett 1995 Jun 8 3
59 7605578 Characterization of a murine p53ser246 mutant equivalent to the human p53ser249 associated with hepatocellular carcinoma and aflatoxin exposure. Mol Carcinog 1995 Jun 1
60 7646765 p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Mol Carcinog 1995 Aug 2
61 7651731 Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants. Oncogene 1995 Aug 17 4
62 7663513 A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 1995 Jun 3
63 7664260 Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res 1995 Sep 15 1
64 7669947 Protein expression of p53 and Rb suppressor genes during the first passages of human endometrial adenocarcinomas heterotransplanted into nude mice. In Vivo 1995 Jan-Feb 1
65 7690928 Targeting and degradation of p53 by E6 of human papillomavirus type 16 is preferential for the 1620+ p53 conformation. Oncogene 1993 Oct 1
66 7735330 A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2. Cell Mol Biol Res 1994 2
67 7735333 Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin. Cell Mol Biol Res 1994 4
68 7753562 p53-dependent growth arrest following calcium phosphate-mediated transfection of murine fibroblasts. Oncogene 1995 May 4 1
69 7761100 MDM2 protein confers the resistance of a human glioblastoma cell line to cisplatin-induced apoptosis. Oncogene 1995 May 18 2
70 7773294 A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53-deficient mice. Nat Genet 1995 Mar 3
71 7784054 Raf phosphorylates p53 in vitro and potentiates p53-dependent transcriptional transactivation in vivo. Oncogene 1995 Jun 1 2
72 7791795 Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995 Jul 7
73 7791802 Molecular and genetic toxicology of 1,3-butadiene. Mutat Res 1995 Jun 1
74 7818762 Mutation, loss of heterozygosity, and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Mol Carcinog 1995 Jan 1
75 7824276 Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 1995 Jan 5 18
76 7845681 Structural and kinetic analysis of p53-DNA complexes and comparison of human and murine p53. Oncogene 1995 Feb 2 1
77 7883788 The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 1994 1
78 7890669 p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase, JNK1. J Biol Chem 1995 Mar 10 5
79 7912076 Metastasis-associated mts1 gene expression correlates with increased p53 detection in the B16 murine melanoma. DNA Cell Biol 1994 Apr 2
80 7934955 The application of the restriction site mutation assay to the study of the induction of mutations in the tissues of rodents. Mutagenesis 1994 May 1
81 7936649 The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene 1994 Nov 3
82 7947386 Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ 1994 Jul 2
83 7970701 Strand-specific removal of cyclobutane pyrimidine dimers from the p53 gene in the epidermis of UVB-irradiated hairless mice. Oncogene 1994 Dec 3
84 7973635 p53 status and the efficacy of cancer therapy in vivo. Science 1994 Nov 4 1
85 7982204 Detection of p53 and histopathological classification of skin tumours induced by halogen lamps in hairless mice. Cancer Lett 1994 Nov 11 2
86 8020138 Increase in p53 protein half-life in mouse keratinocytes following UV-B irradiation. Carcinogenesis 1994 Jun 4
87 8033315 The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis 1994 Jul 5
88 8055640 Murine squamous cell carcinoma cell lines produced by a complete carcinogenesis protocol with benzo[a]pyrene exhibit characteristic p53 mutations and the absence of H-ras and cyl 1/cyclin D1 abnormalities. Carcinogenesis 1994 Aug 1
89 8065163 Alteration of p53 conformation and induction of apoptosis in a murine erythroleukemia cell line by dimethylsulfoxide. Leuk Res 1994 Aug 4
90 8084615 Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site. Oncogene 1994 Oct 3
91 8108142 Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994 Mar 1
92 8114705 Endogenous p53 protein generated from wild-type alternatively spliced p53 RNA in mouse epidermal cells. Mol Cell Biol 1994 Mar 1
93 8142011 Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Mol Carcinog 1994 Feb 2
94 8142019 Infrequent p53 mutations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol Carcinog 1994 Mar 8
95 8149494 Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 1994 Apr 1
96 8247547 Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. Oncogene 1993 Dec 1
97 8275085 Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993 Nov 1
98 8280370 Association of tumorigenic and nontumorigenic (immunogenic) variants in a mouse T-cell lymphoma with two distinct p53 mutations. Mol Carcinog 1993 4
99 8280378 Dependence of induction of osteocalcin gene expression on the presence of wild-type p53 in a murine osteosarcoma cell line. Mol Carcinog 1993 2
100 8287068 Conformation changes of p53 proteins in regulation of murine T lymphocyte proliferation. Cell Mol Biol Res 1993 2